SANDOVAL DAVID I. (General Counsel) received a stock award from MAXCYTE, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/19/2024ACC: 0001415889-24-008638
Officer· General Counsel
Since Feb 2024
+19.54K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
19.54K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.91K
Price / share
—
Trade value
—
% of position
9.3%
3/15/2024
42K→45.91K
Total
Net shares
+3.91K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2024 | A · Award | +3.91K | — | — | 9.3% | 42K | 45.91K |
| Total | +3.91K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
15.63K shares
Shares
+15.63K
Strike price
4.31
Held after
15.63K
Exercisable
—
3/15/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock15.63K shares | 3/15/2024 | A · Award | +15.63K | 4.31 | — | 15.63K |